Chemical Composition and Backbone Modifications Define Deformability of Nucleic Acid Nanoparticles 由 Laxmi Pandey (18762706)

“...Finally, different chemical modifications introduced to the strands can be used to fine-tune the mechanical properties of the NANPs....”

Uncovering hidden protein modifications with native top-down mass spectrometry 由 Jack L. Bennett (19428651)

主題: “...post-translational modifications...”

Stop codon readthrough for tRNA modification gene deletion mutants. 由 Léo Hardy (22538036)

主題:

Chemical Composition and Backbone Modifications Define Deformability of Nucleic Acid Nanoparticles 由 Laxmi Pandey (18762706)

“...Finally, different chemical modifications introduced to the strands can be used to fine-tune the mechanical properties of the NANPs....”

Functional impact of PG modifications on colony opacity of <i>S. pneumoniae.</i> 由 Xiu-Yuan Li (3328056)

“...<p><b>(A)</b> Illustrative depiction of the two post-synthetic PG modifications. M, <i>N</i>-acetylmuramic acid (NAM). ...”

Chemical Composition and Backbone Modifications Define Deformability of Nucleic Acid Nanoparticles 由 Laxmi Pandey (18762706)

“...Finally, different chemical modifications introduced to the strands can be used to fine-tune the mechanical properties of the NANPs....”

Chemical Composition and Backbone Modifications Define Deformability of Nucleic Acid Nanoparticles 由 Laxmi Pandey (18762706)

“...Finally, different chemical modifications introduced to the strands can be used to fine-tune the mechanical properties of the NANPs....”

Linker Modification Enables Control of Key Functional Group Orientation in Macrocycles 由 Christian Brudy (19468152)

主題:

Molecular masses of the fractions obtained as a result of lysozyme modification with pepsin. 由 Łukasz Tomczyk (785198)

主題:

Linker Modification Enables Control of Key Functional Group Orientation in Macrocycles 由 Christian Brudy (19468152)

主題:

Justification for database selection. 由 Denis Sereno (233155)

Parameter value justifications. 由 Pantelis Vafidis (22615310)

Improved Pharmacokinetic Profiles of HDAC6 Inhibitors via Cap Group Modifications 由 Olasunkanmi O. Olaoye (10131945)

“...Hydroxamic acid (HA)-based HDAC inhibitors often suffer from poor pharmacokinetic (PK) profiles, limiting their in vivo applications. Cap group modification offers a promising strategy to address these challenges. ...”

Improved Pharmacokinetic Profiles of HDAC6 Inhibitors via Cap Group Modifications 由 Olasunkanmi O. Olaoye (10131945)

“...Hydroxamic acid (HA)-based HDAC inhibitors often suffer from poor pharmacokinetic (PK) profiles, limiting their in vivo applications. Cap group modification offers a promising strategy to address these challenges. ...”

Research Progress on Histone Lactylation Modification in Ischemic Stroke: Mechanisms and Therapeutic Potential 由 Wang Tingting (17406365)

主題: “...Histone lactylation modification...”

<b>Lossless Altered Histone Modification Analysis System (LAHMAS)</b>m 由 Jamie Sperger (21646463)

“...The resultant Lossless Altered Histone Modification Analysis System (LAHMAS) employs a PDMS-silane treated glass surface immersed in silicone oil to facilitate lossless liquid handling and prevent sample evaporation. ...”

Modification map illustrating the three-point force system for correcting pronation of the foot. 由 Connor Matton (22226835)

主題:

Summary of Substituted Cysteine Modification and Anesthetic Protection Studies in α1 Subunits. 由 Kieran Bhave (9234643)

主題: “...substituted cysteine modification...”

Genetic modifications of Ad11 for tumor-selectivity and evaluation of tumor-selective replication. 由 Masahisa Hemmi (21601907)

Summary of Substituted Cysteine Modification and Anesthetic Protection Studies in β3 Subunits. 由 Kieran Bhave (9234643)

主題: “...substituted cysteine modification...”